[HTML][HTML] Health risk assessment for cyanobacterial toxins in seafood
V Mulvenna, K Dale, B Priestly, U Mueller… - International journal of …, 2012 - mdpi.com
Cyanobacteria (blue-green algae) are abundant in fresh, brackish and marine waters
worldwide. When toxins produced by cyanobacteria are present in the aquatic environment …
worldwide. When toxins produced by cyanobacteria are present in the aquatic environment …
Issues raised by the reference doses for perfluorooctane sulfonate and perfluorooctanoic acid
On 25th May 2016, the US EPA released reference doses (RfDs) for Perfluorooctane
Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA) of 20 ng/kg/day, which were much …
Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA) of 20 ng/kg/day, which were much …
Nanotechnology: a promising new technology—but how safe?
BG Priestly, AJ Harford, MR Sim - Medical journal of Australia, 2007 - Wiley Online Library
Nanomaterials—a wide variety of materials with a diameter of less than 100 nm—have
unique properties. Nanotechnology is being promoted as the technology that will drive the …
unique properties. Nanotechnology is being promoted as the technology that will drive the …
Dose-dependent toxicity of CCl4 in isolated rat hepatocytes and the effects of hepatoprotective treatments
N Stacey, BG Priestly - Toxicology and Applied Pharmacology, 1978 - Elsevier
The temporal and dose-response relationships of the effects of CCl4 were studied in
isolated rat hepatocytes. CCl4 decreased cell membrane integrity, as measured by the loss …
isolated rat hepatocytes. CCl4 decreased cell membrane integrity, as measured by the loss …
Immunological effects among workers who handle engineered nanoparticles
DC Glass, M Mazhar, S Xiang, P Dean… - Occupational and …, 2017 - oem.bmj.com
Objective To determine whether exposure of workers handling engineered nanoparticles
(ENPs) may result in increased inflammation and changes in lung function. Methods A …
(ENPs) may result in increased inflammation and changes in lung function. Methods A …
Peroxisome proliferators protect against paracetamol hepatotoxicity in mice
FA Nicholls-Grzemski, IC Calder, BG Priestly - Biochemical pharmacology, 1992 - Elsevier
The hepatotoxicity of paracetamol is thought to be mediated by an electrophilic intermediate
N-acetyl-p-benzoquinone imine (NAPQI). Conjugation of NAPQI with reduced glutathione …
N-acetyl-p-benzoquinone imine (NAPQI). Conjugation of NAPQI with reduced glutathione …
Lipid peroxidation in isolated rat hepatocytes: Relationship to toxicity of CCl4, ADPFe3+, and diethyl maleate
N Stacey, BG Priestly - Toxicology and Applied Pharmacology, 1978 - Elsevier
The relationship between lipid peroxidation, glutathione (GSH) content, and CCl4-induced
toxicity was investigated in rat hepatocytes isolated by a collagenase-perfusion technique …
toxicity was investigated in rat hepatocytes isolated by a collagenase-perfusion technique …
Sulfobromophthalein metabolism and excretion in rats with iodomethane-induced depletion of hepatic glutathione
BG PRIESTLY, GL PLAA - Journal of Pharmacology and Experimental …, 1970 - ASPET
Pretreatment of rats with iodomethane (75 mg/kg po) resulted in a depletion of hepatic
glutathione with no observable change in hepatic ultrastructure. When sulfobromophthalein …
glutathione with no observable change in hepatic ultrastructure. When sulfobromophthalein …
Clofibrate-Induced in Vitro Hepatoprotection against Acetaminophen Is Not Due to Altered Glutathione Homeostasis
FA Nicholls-Grzemski, IC Calder… - Toxicological …, 2000 - academic.oup.com
Prior induction of peroxisome proliferation protects mice against the in vivo hepatotoxicity of
acetaminophen and various other bioactivation-dependent toxicants. The mechanisms …
acetaminophen and various other bioactivation-dependent toxicants. The mechanisms …
Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients
AW Harman, DB Frewin, BG Priestly - Psychopharmacology, 1980 - Springer
Antipyrine elimination kinetics were measured in psychotic patients receiving either long-
term chloropromazine or fluphenazine decanoate therapy and in non-medicated control …
term chloropromazine or fluphenazine decanoate therapy and in non-medicated control …